NewsRoom Articles - Page 43 of 154 - PsychedelicNewsWire (PNW)

FridayDec 09, 2022 11:13 am

What Investors Should Know About Psychedelics Clinical Trials

Psychedelics are among the hottest things on the market right now. As more and more studies have indicated that these hallucinogenic drugs can have significant mental health benefits, especially when paired with psychotherapy, interest in psychedelic research has increased significantly. Scientists from around the world are now preparing or already running studies to determine the efficacy of psychedelics such as psilocybin and LSD against mental health conditions such as post-traumatic stress disorder, depression and eating disorders. With the psychedelics drugs market projected to be worth $10.75 billion by 2027, plenty of individual and institutional investors are looking to buy in…

ThursdayDec 08, 2022 12:33 pm

Does VR Have a Place in Psychedelic Therapy?

Interest in psychedelic-assisted therapies has blown up over the past couple of years amid surging interest in psychedelic medications across the mainstream and scientific communities. As America’s mental health crisis has grown, there has been increased interest in alternative treatments that do not have the usual side effects associated with typical pharmaceutical drugs. Psychedelics, long enjoyed in certain circles for their hallucinogenic effects, are now being studied for their potential mental health benefits. Early research reveals that drugs such as psilocybin and ketamine can effectively treat mental health conditions, including depression, PTSD and eating disorders, with minimal side effects. Now,…

WednesdayDec 07, 2022 2:00 pm

DEA Increases Final 2023 Production Quotas for Psychedelics

Recently, the Drug Enforcement Administration (DEA) released its latest quotas for the production for drugs to be used in research next year. The agency’s final quotas show even higher limits for the manufacture of psychedelics such as 5-MeO-DMT, psilocin and MDMA. The figures are even higher than the quotas the agency had earlier proposed last month. The DEA expanded specific quotas even more after considering recommendations made by the public. For instance, the Drug Enforcement Administration set its new psilocin target at 12,000 grams. This is more than double the 2022 production quota of the compound, which is extracted from…

TuesdayDec 06, 2022 1:53 pm

New Study Documents Ayahuasca’s Common Psychological, Physical Side Effects

Ayahuasca is a psychedelic brew that is usually made from the Psychotria viridis and Banisteriopsis caapi plants. The psychedelic has an incredibly long history in South America, with ancient Amazonian tribes using it for religious and spiritual purposes centuries ago. Even though ayahuasca is still used for religious and spiritual reasons by certain communities in Brazil and North America, recent research into psychedelics has also revealed that it has medical applications. Studies have found that ayahuasca may be able to aid in the treatment of certain psychiatric disorders and addictions, but most researchers agree that more analysis is needed to…

MondayDec 05, 2022 1:11 pm

Philadelphia Therapist Takes Us Through a Ketamine Therapy Session

Psychedelics are all the rage right now. After seeing their heyday in the 1960s and 1970s, psychedelics spent decades in relative obscurity after federal and state governments opted to ban their production and consumption. However, a surge in psychedelic interest has recently seen millions of dollars invested in developing psychedelic therapies to treat mental health issues such as depression and PTSD. This “psychedelic renaissance” has also been accompanied by an explosion of public interest, with many people around the country looking to use drugs such as ketamine and psilocybin for recreational, medical and spiritual purposes. But the main question for…

FridayDec 02, 2022 12:30 pm

Pharmacologist Uses Comedy to Raise Awareness About Psychedelics

If the news coming out of the psychiatry industry is to be believed, psychedelics are here for the long haul. Outlawed for decades, psychedelics have enjoyed a cult following among recreational users for their hallucinogenic effects. In recent years, however, the scientific community has turned its attention to psychedelics for their potential medical applications. Subsequent studies have revealed that these drugs have the potential to treat mental health issues such as depression and PTSD. However, since most of this research is in its infancy, a lot of the public is simply unaware of psychedelic drugs such as psilocybin and their…

ThursdayDec 01, 2022 3:00 pm

Enrich Your Psychedelic Trip by Listening to These Artists

If you have been paying attention to the internet and the mainstream media for the past couple of years, you probably noticed that psychedelics are all the rage these days. Even though psychedelics are rigidly controlled at the federal level, initial research indicates that they have the potential to alleviate a variety of mental health conditions with relatively few side effects. As a result, millions of dollars have been invested into psychedelic research, and more people are looking to consume hallucinogenic drugs for health, wellness and spiritual purposes. Survey data shows that around 8% of young American adults reported using…

WednesdayNov 30, 2022 1:23 pm

Federal Health Agency Clarifies Guidelines, Priorities for Psychedelic Research

The past couple of years have proven to be a boon for the psychedelics industry. After being outlawed decades ago and subjected to years of prohibition, psychedelics have seen a significant surge in interest among the mainstream and scientific communities. Research and clinical studies have revealed that these drugs have the potential to treat debilitating mental health conditions such as treatment-resistant depression and eating disorders. However, much of this research is in its infancy, mostly due to decades of federal prohibition. The consensus is that more research is needed before psychedelic therapies can be deployed for mass use by the…

TuesdayNov 29, 2022 10:59 am

A Deep Dive into Overcoming Addiction with Psychedelics

Psychedelics have experienced a significant resurgence in popularity over the past couple of years. More and more researchers are looking into the mental health benefits of hallucinogenic drugs, and the public is clamoring for the development of psychedelic therapies. With America in the grip of a mental health crisis, alternative medications such as psychedelics that can alleviate symptoms with minimal side effects are all the rage. Initial studies have found that psychedelics can be quite effective at alleviating the symptoms of a variety of conditions, including post-traumatic stress disorder (PTSD), substance abuse disorder and depression. Recent research published in “JAMA…

MondayNov 28, 2022 10:36 am

Bipartisan Legislators Form Congressional Psychedelics Caucus

Psychedelics have seen a resurgence in scientific and mainstream interest over the past few years. The result has been an increasing body of research showing that psychedelics can have positive mental health impacts, especially when paired with psychiatry. With the public becoming more aware of the long-term side effects of psychiatric medications, the “psychedelic” renaissance couldn’t have come at a better time. Two bipartisan lawmakers have now teamed up to form the first-of-its-kind congressional psychedelics caucus to focus on psychedelic-assisted therapies. The Congressional Psychedelics Advancing Clinical Treatments Caucus will be chaired by Representatives Jack Bergman and Lou Correa. The caucus…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000